23andMe
Latest round
- Series F
Last raised
- Dec 2020
Total raised
- $523M
Investors
- 20
About 23andMe
Based in California, US, 23andMe, Inc. was founded in 2006 by Linda Avey, Paul Cusenza, and Anne Wojcicki. 23andMe is a privately held personal genomics and biotechnology company and is known for providing a direct-to-consumer genetic testing service. The company has been selling products with ancestry and health-related components in Canada since October 2014 and in the UK since December 2014. 23andMe is the first company to begin offering autosomal DNA testing for ancestry in 2007. In October 2020, the company offered a new service called 23andMe+, this makes available additional reports on health and pharmacogenetics and provides ongoing new reports. In October 2021, the firm a portfolio company of Altimeter Capital Management, Euclidean Capital, Fidelity Investments, Foundation Asset Management, G Squared, GSK Ventures, National Human Genome Research Institute, NewView Capital, Pegasus Tech Ventures, Roche Venture Fund, SharesPost, and Xfund acquired LMND Medical Group, Inc. from 415 Ventures, Adaptive Health Capital, Correlation Ventures, Hikma Ventures, Novartis Venture Fund, Vega Ventures, ARTIS Ventures, Endurance Companies, Health Velocity Capital, OTV, and Sierra Ventures for 400 million dollars. 23andMe, Inc. platform is offering gene indexing while highlighting important findings through web-based tools and allows patients to have insights into personal ancestry, genealogy, and inherited traits.
Who invested in 23andMe
20 investors across 8 rounds
See all investors in 23andMe
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Dec 9, 2020
Amount
$83M
Investors
Series F
Aug 31, 2017
Amount
$250M
Investors
Series E
Jun 18, 2015
Amount
$79M
Investors
Series D
Dec 10, 2012
Amount
$58M
Investors
Series C
Jan 7, 2011
Amount
$5.6M
Investors
Series C
Nov 5, 2010
Amount
$22M
Investors
Series B
Dec 22, 2009
Amount
$17M
Investors
Series A
Sep 21, 2007
Amount
$8.9M
Investors
Questions about 23andMe
Who invested in 23andMe?
23andMe has 20 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 23andMe raised?
23andMe has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did 23andMe last raise money?
23andMe's most recent round on record is a Series F, in Dec 2020.
What does 23andMe do?
Based in California, US, 23andMe, Inc.
Where is 23andMe headquartered?
23andMe is headquartered in Sunnyvale, US.
Which VCs invest in companies like 23andMe?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at 23andMe's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like 23andMe? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.